Peptide Registry

Vials

Capsules

Liquids

a capsule bottle of REGEN BPC-157/KPV blend - 500mcg/500mcg

REGEN

$129.00

  • Contents: REGEN BPC-157/KPV Blend (BPC-157 Arginate Salt 500mcg / KPV 500mcg)
  • Format: Encapsulated solid
  • Appearance: White to off-white solid
  • Purity: >99%
Quantity Discount Price
1 - 3 - $129.00
4 - 7 10% $116.10
8 + 18% $105.78
SKU: N/A Category: Brand:

Description

REGEN combines BPC-157 Arginate Salt and KPV in 500mcg/500mcg encapsulated format for oral administration research. The two compounds are mechanistically independent: BPC-157 operates through VEGFR2-mediated angiogenic and eNOS signaling; KPV operates through PepT1 transporter-mediated intestinal uptake and receptor-independent NF-kB suppression via IkBa stabilization. KPV’s PepT1 substrate compatibility and the arginate salt BPC-157’s improved gastric stability both specifically support oral delivery, making this combination particularly well-suited to capsule format among peptide research blends.

Storage and Handling

Store in a cool, dry place away from heat, moisture, and direct light. Keep container tightly sealed when not in use. Refer to the lot-specific certificate of analysis for recommended storage conditions.

Compliance Notice

REGEN BPC-157/KPV Blend capsules are supplied for laboratory research use only. They are not intended for human or veterinary use and carry no therapeutic, diagnostic, or clinical indication. This product has not been evaluated by the FDA. By purchasing this product, the buyer confirms it will be used exclusively for controlled research by qualified personnel following appropriate institutional safety procedures.

Frequently Asked Questions

Why is the REGEN blend particularly appropriate for capsule format?

KPV is a PepT1 transporter substrate with documented intestinal epithelial uptake through this mechanism, making oral delivery mechanistically relevant specifically for KPV. BPC-157 Arginate Salt provides improved gastric stability over standard BPC-157. The combination leverages the oral delivery characteristics of both components in a way that other peptide blends cannot claim as directly.

How does REGEN differ from the KLOW vial blend?

KLOW is a four-component vial blend primarily studied via parenteral administration. REGEN is a two-component blend specifically configured for oral research protocols using arginate salt BPC-157 for gastric stability and pairing it with KPV's documented PepT1 oral uptake mechanism. The two blends address different administration routes and experimental contexts.

Related products